Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Postal Ballot
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Themis Biosyn is seeking shareholder approval via postal ballot for two special resolutions. First, to increase borrowing limits from Rs. 100 Crores to Rs. 3,500 Crores (35x increase) and to allow creation of mortgages/charges on company assets to secure borrowings. Second, to increase limits for giving loans, guarantees, investments and acquiring securities up to Rs. 3,500 Crores. The company has entered into an Asset Purchase Agreement with Sanofi to acquire a portfolio of anti-tuberculosis (TB) and anti-infective brands along with associated trademark and intellectual property rights. The acquisition is subject to regulatory approvals. The company cites capacity expansion plans and strategic business initiatives as drivers for the enhanced borrowing limits.
The massive increase in borrowing limits (from Rs. 100 Cr to Rs. 3,500 Cr) signals the company's intent to make a significant acquisition (Sanofi brand portfolio) and fund expansion. This represents a major strategic shift but increases financial leverage risk. Shareholders should monitor whether the acquisition delivers expected returns on this elevated debt level.